Goel, N., Needham, M., Soler-Ferran, D., Cotreau, M. M., Escobar, J., & Greenberg, S. (2022). POS1342 DEPLETION OF KLRG1+ T CELLS IN A FIRST-IN-HUMAN CLINICAL TRIAL OF ABC008 IN INCLUSION BODY MYOSITIS (IBM). In Annals of the Rheumatic Diseases (Vol. 81, pp. 1008–1009). Elsevier BV. https://doi.org/10.1136/annrheumdis-2022-eular.2141

Goel, N., M. Needham, D. Soler-Ferran, M. M. Cotreau, J. Escobar, and S. Greenberg. “POS1342 DEPLETION OF KLRG1+ T CELLS IN A FIRST-IN-HUMAN CLINICAL TRIAL OF ABC008 IN INCLUSION BODY MYOSITIS (IBM).” In Annals of the Rheumatic Diseases, 81:1008–9. Elsevier BV, 2022. https://doi.org/10.1136/annrheumdis-2022-eular.2141.

Goel N, Needham M, Soler-Ferran D, Cotreau MM, Escobar J, Greenberg S. POS1342 DEPLETION OF KLRG1+ T CELLS IN A FIRST-IN-HUMAN CLINICAL TRIAL OF ABC008 IN INCLUSION BODY MYOSITIS (IBM). In: Annals of the Rheumatic Diseases. Elsevier BV; 2022. p. 1008–9.

Goel, N., et al. “POS1342 DEPLETION OF KLRG1+ T CELLS IN A FIRST-IN-HUMAN CLINICAL TRIAL OF ABC008 IN INCLUSION BODY MYOSITIS (IBM).” Annals of the Rheumatic Diseases, vol. 81, Elsevier BV, 2022, pp. 1008–09. Crossref, doi:10.1136/annrheumdis-2022-eular.2141.

Goel N, Needham M, Soler-Ferran D, Cotreau MM, Escobar J, Greenberg S. POS1342 DEPLETION OF KLRG1+ T CELLS IN A FIRST-IN-HUMAN CLINICAL TRIAL OF ABC008 IN INCLUSION BODY MYOSITIS (IBM). Annals of the Rheumatic Diseases. Elsevier BV; 2022. p. 1008–1009.